(19)
(11) EP 1 248 656 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
25.04.2007 Bulletin 2007/17

(45) Mention of the grant of the patent:
21.02.2007 Bulletin 2007/08

(21) Application number: 01908624.8

(22) Date of filing: 18.01.2001
(51) International Patent Classification (IPC): 
A61M 5/20(2006.01)
 A61M 5/315(2006.01)
(86) International application number:
PCT/US2001/001603
(87) International publication number:
WO 2001/052923 (26.07.2001 Gazette 2001/30)

(54)

SHEAR-SENSITIVE INJECTABLE DELIVERY SYSTEM

VERABREICHUNGSSYSTEM FÜR SCHEREMPFINDLICHE ARZNEISTOFFE

SYSTEME D'ADMINISTRATION DE SUBSTANCES INJECTABLES SENSIBLES AU CISAILLEMENT

(84) Designated Contracting States:
DE FR GB IE NL

(30) Priority: 19.01.2000 US 487436

(43) Date of publication of application:
16.10.2002 Bulletin 2002/42

(73) Proprietor: Boston Scientific Limited
Hastings Christ Church, West Indies (BB)

(72) Inventor:
  • GELLMAN, Barry, N.
    North Easton, MA 02356 (US)

(74) Representative: Piésold, Alexander James 
Frank B. Dehn & Co. St Bride's House 10 Salisbury Square
London EC4Y 8JD
London EC4Y 8JD (GB)


(56) References cited: : 
WO-A-94/15660
DE-C- 545 878
US-A- 2 825 134
 DE-A- 3 317 536
FR-A- 2 572 677
US-A- 2 888 923
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).